These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
506 related articles for article (PubMed ID: 17967941)
1. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Zeiser R; Leveson-Gower DB; Zambricki EA; Kambham N; Beilhack A; Loh J; Hou JZ; Negrin RS Blood; 2008 Jan; 111(1):453-62. PubMed ID: 17967941 [TBL] [Abstract][Full Text] [Related]
2. Activated mammalian target of rapamycin is associated with T regulatory cell insufficiency in nasal polyps. Xu G; Xia J; Hua X; Zhou H; Yu C; Liu Z; Cai K; Shi J; Li H Respir Res; 2009 Feb; 10(1):13. PubMed ID: 19250527 [TBL] [Abstract][Full Text] [Related]
3. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation. Wang X; Wang W; Xu J; Le Q Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787 [TBL] [Abstract][Full Text] [Related]
4. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats. Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590 [TBL] [Abstract][Full Text] [Related]
5. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells. Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562 [TBL] [Abstract][Full Text] [Related]
6. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro. Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692 [TBL] [Abstract][Full Text] [Related]
7. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Shin HJ; Baker J; Leveson-Gower DB; Smith AT; Sega EI; Negrin RS Blood; 2011 Aug; 118(8):2342-50. PubMed ID: 21734238 [TBL] [Abstract][Full Text] [Related]
8. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts. Giorgini A; Noble A J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039 [TBL] [Abstract][Full Text] [Related]
9. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin. Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839 [TBL] [Abstract][Full Text] [Related]
10. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells. Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563 [TBL] [Abstract][Full Text] [Related]
11. Indirubin modulates CD4 Zhao Y; Han P; Liu L; Wang X; Xu P; Wang H; Yu T; Sun Y; Li L; Sun T; Liu X; Zhou H; Qiu J; Wang L; Peng J; Xu S; Hou M J Cell Mol Med; 2019 Mar; 23(3):1885-1898. PubMed ID: 30609280 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo. Wu T; Zhang L; Xu K; Sun C; Lei T; Peng J; Liu G; Wang R; Zhao Y Transpl Immunol; 2012 Aug; 27(1):30-8. PubMed ID: 22613676 [TBL] [Abstract][Full Text] [Related]
14. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin. Strauss L; Czystowska M; Szajnik M; Mandapathil M; Whiteside TL PLoS One; 2009 Jun; 4(6):e5994. PubMed ID: 19543393 [TBL] [Abstract][Full Text] [Related]
15. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841 [TBL] [Abstract][Full Text] [Related]
16. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation. Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells. Yang H; Cheng EY; Sharma VK; Lagman M; Chang C; Song P; Ding R; Muthukumar T; Suthanthiran M Transplantation; 2012 Mar; 93(6):580-8. PubMed ID: 22270834 [TBL] [Abstract][Full Text] [Related]
18. [Rapamycin affect the apoptosis of splenic CD4 Lin ZH; Liu H; Zhu L; Yang X; Zhang YP; Qian J; Liu HY Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):196-201. PubMed ID: 29562463 [No Abstract] [Full Text] [Related]
19. Regulatory T cells require mammalian target of rapamycin signaling to maintain both homeostasis and alloantigen-driven proliferation in lymphocyte-replete mice. Wang Y; Camirand G; Lin Y; Froicu M; Deng S; Shlomchik WD; Lakkis FG; Rothstein DM J Immunol; 2011 Mar; 186(5):2809-18. PubMed ID: 21270412 [TBL] [Abstract][Full Text] [Related]
20. [Depressive effect of cigarette smoke extracts on dendritic cells inducing differentiation of CD4+T cells into CD4+CD25+Foxp3+ Tregs]. Liang Y; Zhou G; Zhang L; Liu J; Zhong X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):15-9. PubMed ID: 26728371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]